Studies have demonstrated that IgM and/or IgG antibodies against WT1 were detectable at a higher level in sera in patients with leukemia and myelodysplastic syndrome (MDS) compared with healthy individuals 33,36. This evidence concerns the gene CD40LG and myelodysplastic syndrome.